• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过定点诱变对人血小板环磷酸腺苷磷酸二酯酶(PDE3A)活性位点进行部分表征。

Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.

作者信息

Cheung P P, Yu L, Zhang H, Colman R W

机构信息

Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, 19140, USA.

出版信息

Arch Biochem Biophys. 1998 Dec 1;360(1):99-104. doi: 10.1006/abbi.1998.0915.

DOI:10.1006/abbi.1998.0915
PMID:9826434
Abstract

Phosphodiesterases (PDE) are important for the downregulation of the intracellular level of the second messenger cyclic adenosine monophosphate (cAMP) by hydrolyzing cAMP to 5'AMP. Previous studies from our laboratory suggested that the human platelet PDE3A active site has two essential histidine residues and one cysteine residue. We therefore decided to begin mutating histidines and cysteines in the conserved domain of PDE3A. A truncated but catalytically active recombinant PDE3A protein was expressed in yeast cells. A six-histidine tag was engineered to the carboxyl end to facilitate protein purification by nickel column. This cDNA construct, PDE3ADelta1, was used for the mutant construction. Mutations were introduced by mutant oligonucleotides during PCR or DNA replication and were confirmed by sequencing. The mutant cDNAs were expressed in PDE-deficient yeast host Saccharomyces cerevisiae strain GL62. The expression levels of the recombinant PDE mutant proteins were monitored by Western blotting using a rabbit anti-platelet PDE3A polyclonal antibody. The kcat, KM, and IC50 for cyclic guanosine monophosphate (cGMP) and IC50 for milrinone were determined for each mutant. Two highly conserved histidines and four conserved cysteines were each mutated to alanine. C816 is present in the 44-amino acid insert unique to PDE3. The mutant C816A is poorly expressed (>2%) and probably is not folded appropriately. H840 is the second histidine in the second motif for metal binding, HDXXH. The mutation H840A, although expressed moderately well, has undetectable activity and is probably responsible for binding a bivalent cation, e.g., Mn2+, essential for catalysis. H869 is a highly conserved amino acid not in a metal-binding motif. H869A is well expressed with a normal kcat. However, the Km for cAMP and the IC50 for cGMP are each fourfold greater in the mutant than those in the wild-type recombinant, suggesting that this histidine is in the inhibitory binding site. Three well-conserved cysteines were mutated, but C942A, C945A, and C1013A all had kinetic values similar to the wild type. The results have identified a histidine at the active site essential for catalysis and a second histidine important for inhibitor binding and have further supported the essential nature of the unique 44-amino acid insert.

摘要

磷酸二酯酶(PDE)通过将环磷酸腺苷(cAMP)水解为5'-AMP,对细胞内第二信使cAMP水平的下调起重要作用。我们实验室之前的研究表明,人血小板PDE3A活性位点有两个必需的组氨酸残基和一个半胱氨酸残基。因此,我们决定开始对PDE3A保守结构域中的组氨酸和半胱氨酸进行突变。一种截短但具有催化活性的重组PDE3A蛋白在酵母细胞中表达。在羧基末端设计了一个六个组氨酸的标签,以便通过镍柱进行蛋白质纯化。这个cDNA构建体PDE3ADelta1用于构建突变体。在PCR或DNA复制过程中,通过突变寡核苷酸引入突变,并通过测序进行确认。突变的cDNA在缺乏PDE的酵母宿主酿酒酵母菌株GL62中表达。使用兔抗血小板PDE3A多克隆抗体通过蛋白质印迹法监测重组PDE突变蛋白的表达水平。测定每个突变体对环磷酸鸟苷(cGMP)的kcat、KM和IC50以及对米力农的IC50。两个高度保守的组氨酸和四个保守的半胱氨酸分别突变为丙氨酸。C816存在于PDE3特有的44个氨基酸插入序列中。突变体C816A表达不佳(>2%),可能折叠不当。H840是金属结合基序HDXXH中第二个基序的第二个组氨酸。突变体H840A虽然表达适度良好,但活性检测不到,可能负责结合催化所需的二价阳离子,例如Mn2+。H869是一个高度保守的氨基酸,不在金属结合基序中。H869A表达良好,kcat正常。然而,突变体中cAMP的Km和cGMP的IC50分别比野生型重组体大四倍,表明这个组氨酸位于抑制性结合位点。三个保守的半胱氨酸被突变,但C942A、C945A和C1013A的动力学值都与野生型相似。这些结果确定了活性位点上一个对催化至关重要的组氨酸和另一个对抑制剂结合重要的组氨酸,并进一步支持了独特的44个氨基酸插入序列的本质重要性。

相似文献

1
Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.通过定点诱变对人血小板环磷酸腺苷磷酸二酯酶(PDE3A)活性位点进行部分表征。
Arch Biochem Biophys. 1998 Dec 1;360(1):99-104. doi: 10.1006/abbi.1998.0915.
2
Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.通过基于结晶PDE4B的定点诱变和分子建模鉴定与环核苷酸磷酸二酯酶3A重叠但不同的cAMP和cGMP相互作用位点。
Protein Sci. 2001 Aug;10(8):1481-9. doi: 10.1110/ps.6601.
3
Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).两种cGMP抑制性环核苷酸磷酸二酯酶(PDE-3)缺失重组体的表达与特性分析
Cell Biochem Biophys. 1998;29(1-2):89-111. doi: 10.1007/BF02737830.
4
Platelet cyclic adenosine monophosphate phosphodiesterases: targets for regulating platelet-related thrombosis.血小板环磷酸腺苷磷酸二酯酶:调节血小板相关血栓形成的靶点。
Semin Thromb Hemost. 2004 Aug;30(4):451-60. doi: 10.1055/s-2004-833480.
5
Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.利用小麦胚体外翻译系统研究磷酸二酯酶2A(PDE2A)中抑制剂特异性和选择性的结构决定因素。
Biochemistry. 2005 Jun 14;44(23):8312-25. doi: 10.1021/bi047313h.
6
Expression and mutagenesis of the catalytic domain of cGMP-inhibited phosphodiesterase (PDE3) cloned from human platelets.从人血小板中克隆的环磷酸鸟苷抑制性磷酸二酯酶(PDE3)催化结构域的表达与诱变
Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):217-24. doi: 10.1042/bj3230217.
7
Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis.人血小板cGI-磷酸二酯酶:在酵母中的表达及通过缺失诱变对催化结构域的定位
Blood. 1996 Aug 15;88(4):1321-9.
8
Implications of PDE4 structure on inhibitor selectivity across PDE families.磷酸二酯酶4(PDE4)结构对跨磷酸二酯酶家族抑制剂选择性的影响。
Int J Impot Res. 2004 Jun;16 Suppl 1:S24-7. doi: 10.1038/sj.ijir.3901211.
9
Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.环磷酸鸟苷(cGMP)抑制型和刺激型环磷酸腺苷(cAMP)磷酸二酯酶对人血小板反应的差异调节。
Thromb Haemost. 2002 May;87(5):873-9.
10
Conserved amino acids in metal-binding motifs of PDE3A are involved in substrate and inhibitor binding.磷酸二酯酶3A(PDE3A)金属结合基序中的保守氨基酸参与底物和抑制剂的结合。
Blood. 2000 Jun 1;95(11):3380-6.

引用本文的文献

1
Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A).鉴定和功能研究环核苷酸磷酸二酯酶 3A(PDE3A)中的遗传多态性。
Ann Hum Genet. 2021 Mar;85(2):80-91. doi: 10.1111/ahg.12411. Epub 2020 Nov 28.
2
Comparative Assessment of the New PDE7 Inhibitor - GRMS-55 and Lisofylline in Animal Models of Immune-Related Disorders: A PK/PD Modeling Approach.新型 PDE7 抑制剂-GRMS-55 与利奥西呱在免疫相关性疾病动物模型中的比较评估:基于 PK/PD 模型的研究方法。
Pharm Res. 2020 Jan 2;37(2):19. doi: 10.1007/s11095-019-2727-z.
3
Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
通过基于结晶PDE4B的定点诱变和分子建模鉴定与环核苷酸磷酸二酯酶3A重叠但不同的cAMP和cGMP相互作用位点。
Protein Sci. 2001 Aug;10(8):1481-9. doi: 10.1110/ps.6601.